保齡寶(002286.SZ):年產1.3萬噸赤蘚糖醇擴建項目達產
格隆匯7月28日丨保齡寶(002286.SZ)公佈,公司投資建設的年產1.3萬噸赤蘚糖醇擴建項目於2020年9月開始建設,經過10個月的建設、調試和運行,產能基本達到了設計要求。
赤蘚糖醇作為目前唯一生物發酵工藝製備的糖醇產品和官方認定的零熱量甜味劑,以天然、零熱值、不參與血糖代謝、較高耐受量及酸熱性能穩定等特點,在無糖飲品、食品等領域得到廣泛應用,以替代蔗糖等傳統糖源。近年來,受國民營養健康行動及市場減糖需求旺盛的影響,赤蘚糖醇等代糖產品受到市場青睞,產品供不應求。公司於2003年在國內率先完成了赤蘚糖醇的產業化,在行業中擁有顯著的技術優勢和品牌優勢。
該項目的達產將進一步提升公司赤蘚糖醇產品的市場佔有率,有利於調整公司產品結構,增強公司競爭能力,將對公司的經營業績帶來積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.